METHOTREXATE BIODIM 25 mg/1 ml, solution for injection bottle, 1 ml
Brand page: Novatrex, Imeth (methotrexate) — all forms and strengths in France
Active ingredients: Methotrexate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 1 mlintraartérielle;intramusculaire;intrathécale;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METHOTREXATE BIODIM 25 mg/1 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intramusculaire;intrathécale;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60353108CIP73160218CIP133400931602187Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOTREXATEsolution | 25 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.